CERA | ELSIhub Events
schedule
13 upcoming events
Follow the calendar
Now click the "Follow calendar" button below to get the
events on your own calendar.
Step 2 of 2
When you subscribe to this calendar, all of the events in the calendar will appear on your own calendar. When the calendar owner creates new events, they'll automatically appear on your calendar. It's like magic.
lightbulb_outline
Upcoming events
south_america expand_more Time shown in+00:00 UTC
11 Sep
ELSI Friday Forum | September 11th, 2026 | 12PM ET/ 9AM PT via Zoom
Beyond Consent and Controlled Access: Governance of Human Biodata Repositories and Global Data Sharing
Moderator: Pilar Ossorio, PhD, JD
Presenters: Joy Zhang, PhD, MSc, Keymanthri Moodley, D.Phil, MD
The mechanisms we rely on to legitimate the sharing of human health and genomic data such as controlled access, accreditation and data use agreements; data protection law, de-identification and formal consent are being outpaced by the scale and geopolitics of the transnational genomic research economy. This forum examines two recent episodes that expose their limits: 1) the sale of de-identified data from the UK Biobank on a commercial platform in China after three accredited institutions violated their access agreements and 2) public objection to a multibillion-dollar "data-for-funding" agreement between the US and Kenya proposed to trade healthcare investment for access to de-identified national health data.
These cases raise questions about the governance of global data sharing. Who sets the terms for data sharing, who bears downstream risks and derives benefit, and whose consent or sovereignty is recognized? The panel asks what trustworthy data sharing requires when data moves across borders under conditions of inequality, and what would have to change, in design and in practice, for global health and genomic data sharing to be trustworthy?
Beyond Consent and Controlled Access: Governance of Human Biodata Repositories and Global Data Sharing
Moderator: Pilar Ossorio, PhD, JD
Presenters: Joy Zhang, PhD, MSc, Keymanthri Moodley, D.Phil, MD
The mechanisms we rely on to legitimate the sharing of human health and genomic data such as controlled access, accreditation and data use agreements; data protection law, de-identification and formal consent are being outpaced by the scale and geopolitics of the transnational genomic research economy. This forum examines two recent episodes that expose their limits: 1) the sale of de-identified data from the UK Biobank on a commercial platform in China after three accredited institutions violated their access agreements and 2) public objection to a multibillion-dollar "data-for-funding" agreement between the US and Kenya proposed to trade healthcare investment for access to de-identified national health data.
These cases raise questions about the governance of global data sharing. Who sets the terms for data sharing, who bears downstream risks and derives benefit, and whose consent or sovereignty is recognized? The panel asks what trustworthy data sharing requires when data moves across borders under conditions of inequality, and what would have to change, in design and in practice, for global health and genomic data sharing to be trustworthy?
https://us06web.zoom.us/j/89098444304?pwd=bFYBPeXi0eCMgOQXCnkNc7kBHkgrWG.1
02 Oct
ELSIconversations | October 2nd, 2026 | 1PM ET/ 10AM PT via Zoom
Moderator: Alison Bateman-House, PhD, MPH, MA
Presenter: Arthur Caplan, PhD
Moderator: Alison Bateman-House, PhD, MPH, MA
Presenter: Arthur Caplan, PhD
https://us06web.zoom.us/j/84856749053?pwd=AqPapeEA1rMifDb0OEiaP8asAEcVgP.1
09 Oct
ELSI Friday Forum | September 11th, 2026 | 12PM ET/ 9AM PT via Zoom
Beyond Consent and Controlled Access: Governance of Human Biodata Repositories and Global Data Sharing
Moderator: Pilar Ossorio, PhD, JD
Presenters: Joy Zhang, PhD, MSc, Keymanthri Moodley, D.Phil, MD
The mechanisms we rely on to legitimate the sharing of human health and genomic data such as controlled access, accreditation and data use agreements; data protection law, de-identification and formal consent are being outpaced by the scale and geopolitics of the transnational genomic research economy. This forum examines two recent episodes that expose their limits: 1) the sale of de-identified data from the UK Biobank on a commercial platform in China after three accredited institutions violated their access agreements and 2) public objection to a multibillion-dollar "data-for-funding" agreement between the US and Kenya proposed to trade healthcare investment for access to de-identified national health data.
These cases raise questions about the governance of global data sharing. Who sets the terms for data sharing, who bears downstream risks and derives benefit, and whose consent or sovereignty is recognized? The panel asks what trustworthy data sharing requires when data moves across borders under conditions of inequality, and what would have to change, in design and in practice, for global health and genomic data sharing to be trustworthy?
Beyond Consent and Controlled Access: Governance of Human Biodata Repositories and Global Data Sharing
Moderator: Pilar Ossorio, PhD, JD
Presenters: Joy Zhang, PhD, MSc, Keymanthri Moodley, D.Phil, MD
The mechanisms we rely on to legitimate the sharing of human health and genomic data such as controlled access, accreditation and data use agreements; data protection law, de-identification and formal consent are being outpaced by the scale and geopolitics of the transnational genomic research economy. This forum examines two recent episodes that expose their limits: 1) the sale of de-identified data from the UK Biobank on a commercial platform in China after three accredited institutions violated their access agreements and 2) public objection to a multibillion-dollar "data-for-funding" agreement between the US and Kenya proposed to trade healthcare investment for access to de-identified national health data.
These cases raise questions about the governance of global data sharing. Who sets the terms for data sharing, who bears downstream risks and derives benefit, and whose consent or sovereignty is recognized? The panel asks what trustworthy data sharing requires when data moves across borders under conditions of inequality, and what would have to change, in design and in practice, for global health and genomic data sharing to be trustworthy?
https://us06web.zoom.us/j/89098444304?pwd=bFYBPeXi0eCMgOQXCnkNc7kBHkgrWG.1
30 Oct
ELSIconversations: ELSIconversations: Exploring the E in ELSI | October 30th, 2026 | 12PM ET/ 9AM PT via Zoom
https://us06web.zoom.us/j/89962975390?pwd=h48nX7nBK8UbAmQXYthOCZ5PWbAK8S.1
13 Nov
ELSI Friday Forum | September 11th, 2026 | 12PM ET/ 9AM PT via Zoom
Beyond Consent and Controlled Access: Governance of Human Biodata Repositories and Global Data Sharing
Moderator: Pilar Ossorio, PhD, JD
Presenters: Joy Zhang, PhD, MSc, Keymanthri Moodley, D.Phil, MD
The mechanisms we rely on to legitimate the sharing of human health and genomic data such as controlled access, accreditation and data use agreements; data protection law, de-identification and formal consent are being outpaced by the scale and geopolitics of the transnational genomic research economy. This forum examines two recent episodes that expose their limits: 1) the sale of de-identified data from the UK Biobank on a commercial platform in China after three accredited institutions violated their access agreements and 2) public objection to a multibillion-dollar "data-for-funding" agreement between the US and Kenya proposed to trade healthcare investment for access to de-identified national health data.
These cases raise questions about the governance of global data sharing. Who sets the terms for data sharing, who bears downstream risks and derives benefit, and whose consent or sovereignty is recognized? The panel asks what trustworthy data sharing requires when data moves across borders under conditions of inequality, and what would have to change, in design and in practice, for global health and genomic data sharing to be trustworthy?
Beyond Consent and Controlled Access: Governance of Human Biodata Repositories and Global Data Sharing
Moderator: Pilar Ossorio, PhD, JD
Presenters: Joy Zhang, PhD, MSc, Keymanthri Moodley, D.Phil, MD
The mechanisms we rely on to legitimate the sharing of human health and genomic data such as controlled access, accreditation and data use agreements; data protection law, de-identification and formal consent are being outpaced by the scale and geopolitics of the transnational genomic research economy. This forum examines two recent episodes that expose their limits: 1) the sale of de-identified data from the UK Biobank on a commercial platform in China after three accredited institutions violated their access agreements and 2) public objection to a multibillion-dollar "data-for-funding" agreement between the US and Kenya proposed to trade healthcare investment for access to de-identified national health data.
These cases raise questions about the governance of global data sharing. Who sets the terms for data sharing, who bears downstream risks and derives benefit, and whose consent or sovereignty is recognized? The panel asks what trustworthy data sharing requires when data moves across borders under conditions of inequality, and what would have to change, in design and in practice, for global health and genomic data sharing to be trustworthy?
https://us06web.zoom.us/j/89098444304?pwd=bFYBPeXi0eCMgOQXCnkNc7kBHkgrWG.1
11 Dec
ELSI Friday Forum | September 11th, 2026 | 12PM ET/ 9AM PT via Zoom
Beyond Consent and Controlled Access: Governance of Human Biodata Repositories and Global Data Sharing
Moderator: Pilar Ossorio, PhD, JD
Presenters: Joy Zhang, PhD, MSc, Keymanthri Moodley, D.Phil, MD
The mechanisms we rely on to legitimate the sharing of human health and genomic data such as controlled access, accreditation and data use agreements; data protection law, de-identification and formal consent are being outpaced by the scale and geopolitics of the transnational genomic research economy. This forum examines two recent episodes that expose their limits: 1) the sale of de-identified data from the UK Biobank on a commercial platform in China after three accredited institutions violated their access agreements and 2) public objection to a multibillion-dollar "data-for-funding" agreement between the US and Kenya proposed to trade healthcare investment for access to de-identified national health data.
These cases raise questions about the governance of global data sharing. Who sets the terms for data sharing, who bears downstream risks and derives benefit, and whose consent or sovereignty is recognized? The panel asks what trustworthy data sharing requires when data moves across borders under conditions of inequality, and what would have to change, in design and in practice, for global health and genomic data sharing to be trustworthy?
Beyond Consent and Controlled Access: Governance of Human Biodata Repositories and Global Data Sharing
Moderator: Pilar Ossorio, PhD, JD
Presenters: Joy Zhang, PhD, MSc, Keymanthri Moodley, D.Phil, MD
The mechanisms we rely on to legitimate the sharing of human health and genomic data such as controlled access, accreditation and data use agreements; data protection law, de-identification and formal consent are being outpaced by the scale and geopolitics of the transnational genomic research economy. This forum examines two recent episodes that expose their limits: 1) the sale of de-identified data from the UK Biobank on a commercial platform in China after three accredited institutions violated their access agreements and 2) public objection to a multibillion-dollar "data-for-funding" agreement between the US and Kenya proposed to trade healthcare investment for access to de-identified national health data.
These cases raise questions about the governance of global data sharing. Who sets the terms for data sharing, who bears downstream risks and derives benefit, and whose consent or sovereignty is recognized? The panel asks what trustworthy data sharing requires when data moves across borders under conditions of inequality, and what would have to change, in design and in practice, for global health and genomic data sharing to be trustworthy?
https://us06web.zoom.us/j/89098444304?pwd=bFYBPeXi0eCMgOQXCnkNc7kBHkgrWG.1
08 Jan
ELSI Friday Forum | September 11th, 2026 | 12PM ET/ 9AM PT via Zoom
Beyond Consent and Controlled Access: Governance of Human Biodata Repositories and Global Data Sharing
Moderator: Pilar Ossorio, PhD, JD
Presenters: Joy Zhang, PhD, MSc, Keymanthri Moodley, D.Phil, MD
The mechanisms we rely on to legitimate the sharing of human health and genomic data such as controlled access, accreditation and data use agreements; data protection law, de-identification and formal consent are being outpaced by the scale and geopolitics of the transnational genomic research economy. This forum examines two recent episodes that expose their limits: 1) the sale of de-identified data from the UK Biobank on a commercial platform in China after three accredited institutions violated their access agreements and 2) public objection to a multibillion-dollar "data-for-funding" agreement between the US and Kenya proposed to trade healthcare investment for access to de-identified national health data.
These cases raise questions about the governance of global data sharing. Who sets the terms for data sharing, who bears downstream risks and derives benefit, and whose consent or sovereignty is recognized? The panel asks what trustworthy data sharing requires when data moves across borders under conditions of inequality, and what would have to change, in design and in practice, for global health and genomic data sharing to be trustworthy?
Beyond Consent and Controlled Access: Governance of Human Biodata Repositories and Global Data Sharing
Moderator: Pilar Ossorio, PhD, JD
Presenters: Joy Zhang, PhD, MSc, Keymanthri Moodley, D.Phil, MD
The mechanisms we rely on to legitimate the sharing of human health and genomic data such as controlled access, accreditation and data use agreements; data protection law, de-identification and formal consent are being outpaced by the scale and geopolitics of the transnational genomic research economy. This forum examines two recent episodes that expose their limits: 1) the sale of de-identified data from the UK Biobank on a commercial platform in China after three accredited institutions violated their access agreements and 2) public objection to a multibillion-dollar "data-for-funding" agreement between the US and Kenya proposed to trade healthcare investment for access to de-identified national health data.
These cases raise questions about the governance of global data sharing. Who sets the terms for data sharing, who bears downstream risks and derives benefit, and whose consent or sovereignty is recognized? The panel asks what trustworthy data sharing requires when data moves across borders under conditions of inequality, and what would have to change, in design and in practice, for global health and genomic data sharing to be trustworthy?
https://us06web.zoom.us/j/89098444304?pwd=bFYBPeXi0eCMgOQXCnkNc7kBHkgrWG.1
12 Feb
ELSI Friday Forum | September 11th, 2026 | 12PM ET/ 9AM PT via Zoom
Beyond Consent and Controlled Access: Governance of Human Biodata Repositories and Global Data Sharing
Moderator: Pilar Ossorio, PhD, JD
Presenters: Joy Zhang, PhD, MSc, Keymanthri Moodley, D.Phil, MD
The mechanisms we rely on to legitimate the sharing of human health and genomic data such as controlled access, accreditation and data use agreements; data protection law, de-identification and formal consent are being outpaced by the scale and geopolitics of the transnational genomic research economy. This forum examines two recent episodes that expose their limits: 1) the sale of de-identified data from the UK Biobank on a commercial platform in China after three accredited institutions violated their access agreements and 2) public objection to a multibillion-dollar "data-for-funding" agreement between the US and Kenya proposed to trade healthcare investment for access to de-identified national health data.
These cases raise questions about the governance of global data sharing. Who sets the terms for data sharing, who bears downstream risks and derives benefit, and whose consent or sovereignty is recognized? The panel asks what trustworthy data sharing requires when data moves across borders under conditions of inequality, and what would have to change, in design and in practice, for global health and genomic data sharing to be trustworthy?
Beyond Consent and Controlled Access: Governance of Human Biodata Repositories and Global Data Sharing
Moderator: Pilar Ossorio, PhD, JD
Presenters: Joy Zhang, PhD, MSc, Keymanthri Moodley, D.Phil, MD
The mechanisms we rely on to legitimate the sharing of human health and genomic data such as controlled access, accreditation and data use agreements; data protection law, de-identification and formal consent are being outpaced by the scale and geopolitics of the transnational genomic research economy. This forum examines two recent episodes that expose their limits: 1) the sale of de-identified data from the UK Biobank on a commercial platform in China after three accredited institutions violated their access agreements and 2) public objection to a multibillion-dollar "data-for-funding" agreement between the US and Kenya proposed to trade healthcare investment for access to de-identified national health data.
These cases raise questions about the governance of global data sharing. Who sets the terms for data sharing, who bears downstream risks and derives benefit, and whose consent or sovereignty is recognized? The panel asks what trustworthy data sharing requires when data moves across borders under conditions of inequality, and what would have to change, in design and in practice, for global health and genomic data sharing to be trustworthy?
https://us06web.zoom.us/j/89098444304?pwd=bFYBPeXi0eCMgOQXCnkNc7kBHkgrWG.1
12 Mar
ELSI Friday Forum | September 11th, 2026 | 12PM ET/ 9AM PT via Zoom
Beyond Consent and Controlled Access: Governance of Human Biodata Repositories and Global Data Sharing
Moderator: Pilar Ossorio, PhD, JD
Presenters: Joy Zhang, PhD, MSc, Keymanthri Moodley, D.Phil, MD
The mechanisms we rely on to legitimate the sharing of human health and genomic data such as controlled access, accreditation and data use agreements; data protection law, de-identification and formal consent are being outpaced by the scale and geopolitics of the transnational genomic research economy. This forum examines two recent episodes that expose their limits: 1) the sale of de-identified data from the UK Biobank on a commercial platform in China after three accredited institutions violated their access agreements and 2) public objection to a multibillion-dollar "data-for-funding" agreement between the US and Kenya proposed to trade healthcare investment for access to de-identified national health data.
These cases raise questions about the governance of global data sharing. Who sets the terms for data sharing, who bears downstream risks and derives benefit, and whose consent or sovereignty is recognized? The panel asks what trustworthy data sharing requires when data moves across borders under conditions of inequality, and what would have to change, in design and in practice, for global health and genomic data sharing to be trustworthy?
Beyond Consent and Controlled Access: Governance of Human Biodata Repositories and Global Data Sharing
Moderator: Pilar Ossorio, PhD, JD
Presenters: Joy Zhang, PhD, MSc, Keymanthri Moodley, D.Phil, MD
The mechanisms we rely on to legitimate the sharing of human health and genomic data such as controlled access, accreditation and data use agreements; data protection law, de-identification and formal consent are being outpaced by the scale and geopolitics of the transnational genomic research economy. This forum examines two recent episodes that expose their limits: 1) the sale of de-identified data from the UK Biobank on a commercial platform in China after three accredited institutions violated their access agreements and 2) public objection to a multibillion-dollar "data-for-funding" agreement between the US and Kenya proposed to trade healthcare investment for access to de-identified national health data.
These cases raise questions about the governance of global data sharing. Who sets the terms for data sharing, who bears downstream risks and derives benefit, and whose consent or sovereignty is recognized? The panel asks what trustworthy data sharing requires when data moves across borders under conditions of inequality, and what would have to change, in design and in practice, for global health and genomic data sharing to be trustworthy?
https://us06web.zoom.us/j/89098444304?pwd=bFYBPeXi0eCMgOQXCnkNc7kBHkgrWG.1
09 Apr
ELSI Friday Forum | September 11th, 2026 | 12PM ET/ 9AM PT via Zoom
Beyond Consent and Controlled Access: Governance of Human Biodata Repositories and Global Data Sharing
Moderator: Pilar Ossorio, PhD, JD
Presenters: Joy Zhang, PhD, MSc, Keymanthri Moodley, D.Phil, MD
The mechanisms we rely on to legitimate the sharing of human health and genomic data such as controlled access, accreditation and data use agreements; data protection law, de-identification and formal consent are being outpaced by the scale and geopolitics of the transnational genomic research economy. This forum examines two recent episodes that expose their limits: 1) the sale of de-identified data from the UK Biobank on a commercial platform in China after three accredited institutions violated their access agreements and 2) public objection to a multibillion-dollar "data-for-funding" agreement between the US and Kenya proposed to trade healthcare investment for access to de-identified national health data.
These cases raise questions about the governance of global data sharing. Who sets the terms for data sharing, who bears downstream risks and derives benefit, and whose consent or sovereignty is recognized? The panel asks what trustworthy data sharing requires when data moves across borders under conditions of inequality, and what would have to change, in design and in practice, for global health and genomic data sharing to be trustworthy?
Beyond Consent and Controlled Access: Governance of Human Biodata Repositories and Global Data Sharing
Moderator: Pilar Ossorio, PhD, JD
Presenters: Joy Zhang, PhD, MSc, Keymanthri Moodley, D.Phil, MD
The mechanisms we rely on to legitimate the sharing of human health and genomic data such as controlled access, accreditation and data use agreements; data protection law, de-identification and formal consent are being outpaced by the scale and geopolitics of the transnational genomic research economy. This forum examines two recent episodes that expose their limits: 1) the sale of de-identified data from the UK Biobank on a commercial platform in China after three accredited institutions violated their access agreements and 2) public objection to a multibillion-dollar "data-for-funding" agreement between the US and Kenya proposed to trade healthcare investment for access to de-identified national health data.
These cases raise questions about the governance of global data sharing. Who sets the terms for data sharing, who bears downstream risks and derives benefit, and whose consent or sovereignty is recognized? The panel asks what trustworthy data sharing requires when data moves across borders under conditions of inequality, and what would have to change, in design and in practice, for global health and genomic data sharing to be trustworthy?
https://us06web.zoom.us/j/89098444304?pwd=bFYBPeXi0eCMgOQXCnkNc7kBHkgrWG.1
14 May
ELSI Friday Forum | September 11th, 2026 | 12PM ET/ 9AM PT via Zoom
Beyond Consent and Controlled Access: Governance of Human Biodata Repositories and Global Data Sharing
Moderator: Pilar Ossorio, PhD, JD
Presenters: Joy Zhang, PhD, MSc, Keymanthri Moodley, D.Phil, MD
The mechanisms we rely on to legitimate the sharing of human health and genomic data such as controlled access, accreditation and data use agreements; data protection law, de-identification and formal consent are being outpaced by the scale and geopolitics of the transnational genomic research economy. This forum examines two recent episodes that expose their limits: 1) the sale of de-identified data from the UK Biobank on a commercial platform in China after three accredited institutions violated their access agreements and 2) public objection to a multibillion-dollar "data-for-funding" agreement between the US and Kenya proposed to trade healthcare investment for access to de-identified national health data.
These cases raise questions about the governance of global data sharing. Who sets the terms for data sharing, who bears downstream risks and derives benefit, and whose consent or sovereignty is recognized? The panel asks what trustworthy data sharing requires when data moves across borders under conditions of inequality, and what would have to change, in design and in practice, for global health and genomic data sharing to be trustworthy?
Beyond Consent and Controlled Access: Governance of Human Biodata Repositories and Global Data Sharing
Moderator: Pilar Ossorio, PhD, JD
Presenters: Joy Zhang, PhD, MSc, Keymanthri Moodley, D.Phil, MD
The mechanisms we rely on to legitimate the sharing of human health and genomic data such as controlled access, accreditation and data use agreements; data protection law, de-identification and formal consent are being outpaced by the scale and geopolitics of the transnational genomic research economy. This forum examines two recent episodes that expose their limits: 1) the sale of de-identified data from the UK Biobank on a commercial platform in China after three accredited institutions violated their access agreements and 2) public objection to a multibillion-dollar "data-for-funding" agreement between the US and Kenya proposed to trade healthcare investment for access to de-identified national health data.
These cases raise questions about the governance of global data sharing. Who sets the terms for data sharing, who bears downstream risks and derives benefit, and whose consent or sovereignty is recognized? The panel asks what trustworthy data sharing requires when data moves across borders under conditions of inequality, and what would have to change, in design and in practice, for global health and genomic data sharing to be trustworthy?
https://us06web.zoom.us/j/89098444304?pwd=bFYBPeXi0eCMgOQXCnkNc7kBHkgrWG.1
11 Jun
ELSI Friday Forum | September 11th, 2026 | 12PM ET/ 9AM PT via Zoom
Beyond Consent and Controlled Access: Governance of Human Biodata Repositories and Global Data Sharing
Moderator: Pilar Ossorio, PhD, JD
Presenters: Joy Zhang, PhD, MSc, Keymanthri Moodley, D.Phil, MD
The mechanisms we rely on to legitimate the sharing of human health and genomic data such as controlled access, accreditation and data use agreements; data protection law, de-identification and formal consent are being outpaced by the scale and geopolitics of the transnational genomic research economy. This forum examines two recent episodes that expose their limits: 1) the sale of de-identified data from the UK Biobank on a commercial platform in China after three accredited institutions violated their access agreements and 2) public objection to a multibillion-dollar "data-for-funding" agreement between the US and Kenya proposed to trade healthcare investment for access to de-identified national health data.
These cases raise questions about the governance of global data sharing. Who sets the terms for data sharing, who bears downstream risks and derives benefit, and whose consent or sovereignty is recognized? The panel asks what trustworthy data sharing requires when data moves across borders under conditions of inequality, and what would have to change, in design and in practice, for global health and genomic data sharing to be trustworthy?
Beyond Consent and Controlled Access: Governance of Human Biodata Repositories and Global Data Sharing
Moderator: Pilar Ossorio, PhD, JD
Presenters: Joy Zhang, PhD, MSc, Keymanthri Moodley, D.Phil, MD
The mechanisms we rely on to legitimate the sharing of human health and genomic data such as controlled access, accreditation and data use agreements; data protection law, de-identification and formal consent are being outpaced by the scale and geopolitics of the transnational genomic research economy. This forum examines two recent episodes that expose their limits: 1) the sale of de-identified data from the UK Biobank on a commercial platform in China after three accredited institutions violated their access agreements and 2) public objection to a multibillion-dollar "data-for-funding" agreement between the US and Kenya proposed to trade healthcare investment for access to de-identified national health data.
These cases raise questions about the governance of global data sharing. Who sets the terms for data sharing, who bears downstream risks and derives benefit, and whose consent or sovereignty is recognized? The panel asks what trustworthy data sharing requires when data moves across borders under conditions of inequality, and what would have to change, in design and in practice, for global health and genomic data sharing to be trustworthy?
https://us06web.zoom.us/j/89098444304?pwd=bFYBPeXi0eCMgOQXCnkNc7kBHkgrWG.1
09 Jul
ELSI Friday Forum | September 11th, 2026 | 12PM ET/ 9AM PT via Zoom
Beyond Consent and Controlled Access: Governance of Human Biodata Repositories and Global Data Sharing
Moderator: Pilar Ossorio, PhD, JD
Presenters: Joy Zhang, PhD, MSc, Keymanthri Moodley, D.Phil, MD
The mechanisms we rely on to legitimate the sharing of human health and genomic data such as controlled access, accreditation and data use agreements; data protection law, de-identification and formal consent are being outpaced by the scale and geopolitics of the transnational genomic research economy. This forum examines two recent episodes that expose their limits: 1) the sale of de-identified data from the UK Biobank on a commercial platform in China after three accredited institutions violated their access agreements and 2) public objection to a multibillion-dollar "data-for-funding" agreement between the US and Kenya proposed to trade healthcare investment for access to de-identified national health data.
These cases raise questions about the governance of global data sharing. Who sets the terms for data sharing, who bears downstream risks and derives benefit, and whose consent or sovereignty is recognized? The panel asks what trustworthy data sharing requires when data moves across borders under conditions of inequality, and what would have to change, in design and in practice, for global health and genomic data sharing to be trustworthy?
Beyond Consent and Controlled Access: Governance of Human Biodata Repositories and Global Data Sharing
Moderator: Pilar Ossorio, PhD, JD
Presenters: Joy Zhang, PhD, MSc, Keymanthri Moodley, D.Phil, MD
The mechanisms we rely on to legitimate the sharing of human health and genomic data such as controlled access, accreditation and data use agreements; data protection law, de-identification and formal consent are being outpaced by the scale and geopolitics of the transnational genomic research economy. This forum examines two recent episodes that expose their limits: 1) the sale of de-identified data from the UK Biobank on a commercial platform in China after three accredited institutions violated their access agreements and 2) public objection to a multibillion-dollar "data-for-funding" agreement between the US and Kenya proposed to trade healthcare investment for access to de-identified national health data.
These cases raise questions about the governance of global data sharing. Who sets the terms for data sharing, who bears downstream risks and derives benefit, and whose consent or sovereignty is recognized? The panel asks what trustworthy data sharing requires when data moves across borders under conditions of inequality, and what would have to change, in design and in practice, for global health and genomic data sharing to be trustworthy?
https://us06web.zoom.us/j/89098444304?pwd=bFYBPeXi0eCMgOQXCnkNc7kBHkgrWG.1